Herba Chemosan nun österreichisch: Management Buy-Out erfolgreich abgeschlossen
Vorstand der Herba Chemosan Unternehmensgruppe gemeinsam mit Invest AG der Raiffeisenbankengruppe OÖ nun Eigentümer des…
Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology
Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A…
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE® AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater…
Center for Precision Medicine at MedUni’s Vienna General Hospital Campus to be named after Nobel Prize winner Eric Kandel
Funded by the European Resilience and Recovery Facility as well as donations, the Center for Precision Medicine (CPM) is…
HealthTech startup myReha raises 2.2 million euros before product launch
The company develops digital stroke rehab that can help 20,000 people in Austria each year.
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
- Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorder
-…
OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF
OncoOne, a biotechnology company focused on discovering precision medicines for cancer and other indications and…
BioNTech to acquire PhagoMed
BioNTech announces third quarter 2021 financial results and corporate update
Für mehr Versorgungssicherheit: AOP Orphan nimmt Verpackungsanlage in Wien in Betrieb
Sieben Medikamente verpackt AOP Orphan ab 2022 am Standort Wien selbst. Damit steigt die Versorgungssicherheit bei…
Spatenstich für HOOKIPA-Produktionsstandort in aspern Die Seestadt Wiens
- Mit der Errichtung der Produktionsanlage PLANT des Biotech-Unternehmens werden im Vollbetrieb bis zu 100 neue…
Boehringer Ingelheim inaugurates biopharmaceutical production facility in Vienna, Austria
- Adds 185,000 litres of biopharmaceutical production capacity
- High degree of digitalization and automation through…
Austrian AOP Orphan to Tap into U.S. Market with Partner Eagle Pharmaceuticals
European rare and special disease pioneer AOP Orphan Pharmaceuticals GmbH has entered into a licensing agreement with…
contextflow Secures EUR 6.7 Million Series A Investment
A second EUR 2 Million closing brings the Vienna-based AI in radiology startup contextflow’s total Series A investment…
AC Immune acquires AFFiRiS’ specific active immunotherapy (SAIT) Anti-Alpha-Synuclein programs targeting neurodegenerative diseases
- AFFiRiS to receive AC Immune stock valued at USD 58.7 million in exchange for its portfolio of therapeutics targeting…
Cutanos closes first financing round with investor consortium from Austria and Germany
Max Planck spin-off develops immunotherapies through innovative platform technology
Boehringer Ingelheim eröffnet in Wien internationales Kompetenzzentrum für Geflügelimpfungen
Boehringer Ingelheim entwickelt laufend neue Impfstoffe zur Vorbeugung von Krankheiten sowie zur Verringerung der…
Exscientia acquires personalised medicine AI pioneer Allcyte
- Deep learning platform evaluates drug activity in patient tumour microenvironments with single cell resolution
-…
WWTF-Life Sciences Call 2020: Mehr als 6 Millionen Euro für Präzisionsmedizin in Wien
Durch die Erforschung ihrer grundlegenden Mechanismen können schwere Krankheiten erkannt und künftig durch stärker…
contextflow announces mid-seven figures Series A Investment
The Austrian-based AI in radiology startup contextflow secured a mid-seven figures Series A investment led by B&C…
Biomay Cooperates with BioNTech to Supply DNA Template for COVID-19 mRNA Vaccine
Biomay, a Vienna based biotech manufacturer, today announced their partnership with BioNTech SE to support the supply…
60 Million Euro investment for Vienna BioCenter Core Facilities
The Vienna BioCenter Core Facilities receive 60 million Euro to maintain and further develop its cutting-edge research…
Delta 4 Announces Closing of Multi-million Series A Financing Round
- Company to Expand Focus Beyond Renal Diseases and COVID-19
- Compounds Identified in Current Discovery Programs Ready…
Austrian biotech Allcyte raises $6m seed round following breakthrough cancer clinical trial
Allcyte uses automated microscopy and AI powered single-cell resolution image analysis on live patient tissue samples to…
CeMM: Solgate closes its first financing round with IST cube and private investors
Joint CeMM-IST Austria start-up develops new class of drugs targeting solute carrier proteins
a:head closes another 7-digit EUR financing round
a:head bio AG today closed a second round of financing to fuel its revolutionary approach in combating neurological…
Evologic Technologies: €2,5 million through a new financing round
Financial investments secure the production of biostimulants and biopesticides through a novel, sustainable, and…
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
- Expands Pipeline Beyond Ophthalmology with PP-001, a Clinical Stage, Best-in-Class DHODH Inhibitor
- PP-001 Leverages…
Biomay to construct a new biotech manufacturing facility in Vienna
Tenfold Increase of manufacturing capacities in 2022
HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option
HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary…
QUANTRO Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform
- QUANTRO to enable discovery of novel therapeutics that interfere with disease-causing transcriptional programs in…